XML 18 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholder's Equity (Deficit) - USD ($)
$ in Thousands
Total
Preferred Stock Series A [Member]
Preferred Stock Series A-1 [Member]
Preferred Stock Series B [Member]
Preferred Stock Series B-1 [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2019 $ (58,902) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 $ 2,293 $ (61,197)
Beginning balance (in shares) at Dec. 31, 2019   26,157,622 20,238,201 12,366,306 3,047,183 21,700,713    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options 50           50  
Issuance of common stock upon exercise of stock options (in Shares)           241,444    
Stock-based compensation 181           181
Net loss (2,128)             (2,128)
Ending balance at Mar. 31, 2020 (60,799) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 2,524 (63,325)
Ending balance (in shares) at Mar. 31, 2020   26,157,622 20,238,201 12,366,306 3,047,183 21,942,157    
Beginning balance at Dec. 31, 2019 (58,902) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 2,293 (61,197)
Beginning balance (in shares) at Dec. 31, 2019   26,157,622 20,238,201 12,366,306 3,047,183 21,700,713    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (4,723)              
Ending balance at Sep. 30, 2020 (62,610) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 3,308 (65,920)
Ending balance (in shares) at Sep. 30, 2020   26,157,622 20,238,201 12,366,306 3,047,183 22,033,268    
Beginning balance at Mar. 31, 2020 (60,799) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 2,524 (63,325)
Beginning balance (in shares) at Mar. 31, 2020   26,157,622 20,238,201 12,366,306 3,047,183 21,942,157    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock warrants in connection with debt amendment and new debt issuance 226           226  
Issuance of common stock upon exercise of stock options 19           19  
Issuance of common stock upon exercise of stock options (in Shares)           30,669    
Stock-based compensation 273           273  
Net loss (1,094)             (1,094)
Ending balance at Jun. 30, 2020 (61,375) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 3,042 (64,419)
Ending balance (in shares) at Jun. 30, 2020   26,157,622 20,238,201 12,366,306 3,047,183 21,972,826    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options 18           18  
Issuance of common stock upon exercise of stock options (in Shares)           60,442    
Stock-based compensation 248           248  
Net loss (1,501)             (1,501)
Ending balance at Sep. 30, 2020 (62,610) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 3,308 (65,920)
Ending balance (in shares) at Sep. 30, 2020   26,157,622 20,238,201 12,366,306 3,047,183 22,033,268    
Beginning balance at Dec. 31, 2020 (68,009) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 3,707 (71,718)
Beginning balance (in shares) at Dec. 31, 2020   26,157,622 20,238,201 12,366,306 3,047,183 22,118,619    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options 244           244  
Issuance of common stock upon exercise of stock options (in Shares)           367,432    
Stock-based compensation 828           828  
Net loss (7,857)             (7,857)
Ending balance at Mar. 31, 2021 (74,794) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 4,779 (79,575)
Ending balance (in shares) at Mar. 31, 2021   26,157,622 20,238,201 12,366,306 3,047,183 22,486,051    
Beginning balance at Dec. 31, 2020 $ (68,009) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 3,707 (71,718)
Beginning balance (in shares) at Dec. 31, 2020   26,157,622 20,238,201 12,366,306 3,047,183 22,118,619    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options (in Shares) 526,819              
Net loss $ (47,647)              
Ending balance at Sep. 30, 2021 76,975         $ 11 196,330 (119,366)
Ending balance (in shares) at Sep. 30, 2021           112,818,724    
Beginning balance at Mar. 31, 2021 (74,794) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 4,779 (79,575)
Beginning balance (in shares) at Mar. 31, 2021   26,157,622 20,238,201 12,366,306 3,047,183 22,486,051    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock upon exercise of stock options 24           24  
Issuance of common stock upon exercise of stock options (in Shares)           63,004    
Stock-based compensation 785           785  
Net loss (5,335)             (5,335)
Ending balance at Jun. 30, 2021 (79,320) $ 9,569 $ 14,083 $ 18,854 $ 4,682 $ 2 5,588 (84,910)
Ending balance (in shares) at Jun. 30, 2021   26,157,622 20,238,201 12,366,306 3,047,183 22,549,055    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (Note 2) 47,188 $ (9,569) $ (14,083) $ (18,854) $ (4,682) $ 6 47,182  
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization (in shares)   (26,157,622) (20,238,201) (12,366,306) (3,047,183) 61,809,312    
Conversion of convertible promissory notes to common stock in connection with the reverse recapitalization (Note 6) 7,122         $ 1 7,121  
Conversion of convertible promissory notes to common stock in connection with the reverse recapitalization (in Shares)           4,633,507    
Beneficial conversion feature of convertible promissory notes in connection with the reverse recapitalization (Note 6) 26,061           26,061  
Reverse recapitalization transaction, net of fees 101,035         $ 2 101,033  
Reverse recapitalization transaction, net of fees (in Shares)           21,959,227    
Conversion of preferred stock warrants and common stock warrants in connection with the reverse recapitalization (in shares)           1,771,231    
Conversion of preferred stock warrants and common stock warrants in connection with the reverse recapitalization 8,571           8,571  
Issuance of common stock upon exercise of stock options 77           77  
Issuance of common stock upon exercise of stock options (in Shares)           96,392    
Stock-based compensation 697           697  
Net loss (34,456)             (34,456)
Ending balance at Sep. 30, 2021 $ 76,975         $ 11 $ 196,330 $ (119,366)
Ending balance (in shares) at Sep. 30, 2021           112,818,724